Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Hisse Senetlerindeki Sıralama #31185
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Hisse Fiyatı
$0.03808538
Son senkronizasyon: 2026-08-18
Piyasa Değeri
$14.04M
Değişim (1 gün)
-3.57%
Değişim (1 yıl)
7.27%
Ülke
AU
Ticaret BCAL Diagnostics Limited (BDX)

Kategori

BCAL Diagnostics Limited (BDX) için temettü verimi geçmişi
BCAL Diagnostics Limited (hisse sembolü: BDX) temettü verimi (TTM) 2026 itibariyle: 0
Son 5 yılın ortalama temettü verimi: 0.00%
BCAL Diagnostics Limited (BDX) için 2026 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin temettü verimi (TTM)